Impressive Bisantrene Phase 2 AML Clinical Results
Released 06 Nov 23
Latest announcements
Announcement summary
Impressive Bisantrene Phase 2 AML Clinical Results
Ask a question
Your question will be sent privately to Race Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Race Oncology a question about this announcement.